Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease

Table 3 Reports of parenchymal renal disease induced by dietary hyperoxaluria

Ref.	Daily oxalate intake (mg), duration	Urine oxalate (mg/24 per hour)	Peak SCr (mg/dL)	Clinical diagnosis, course, outcome, final SCr (mg/dL)
150	310, many mo	16.61	1.8	CKD with SCr 1.7-1.8
151	1880, 4 wk	34.22		AKI on diabetic CKD. Progression to ESRD
152	2240-2800, 6 mo	-	8.08	CKD. Progression to ESRD
153a	9000, 4 d	603	6.4	AKI, HDx10 days. SCr 0.9 in 6 wk
153b	4500, 5 d	-	9.3	AKI, HDx6 times. SCr 1.3 in 5 wk
153c	3600, NS	-	6	AKI, No HD. SCr 1.0 in 4 wk
153d	1800, NS	-	5.5	AKI, No HD. SCr 0.8 in 2 wk
153e	5400-6300, NS	-	12.3	AKI, HD. SCr 2.1 in 4 wk
153f	6300-7200, NS.	-	6.7	AKI, no HD. SCr 1.1 in 6 wk
153g	4500-5400, NS	-	9.8	AKI, HD. SCr 1.2 in 6 wk
153h	6300, NS	-	6.6	AKI, HD. SCr 1.1 in 4 wk
153i	2700-3600, NS	-	5.2	AKI, HD. SCr 0.8 in 2 wk
153j	7200 NS	-	10.4	AKI, HD. SCr 1.5 in 6 wk
154	1260, 6 wk	-	7.9	CKD on CKD from HTN. SCr 1.9 in 4 mo
155a	13120, once	74	12	AKI, HDx2 times. SCr 1.3 in 1 yr
155b	9240, once	74	11.7	AKI, no HD. SCr 1.3 in 4 mo
156	450-660, > 3 yr	-	6.9	CKD on other CKD, no HD. SCr 3.4 in 3 mo
157a	3725, once	-	-	AKI, no HD. Final SCr 1.1
157b	4360, once	-	6.3	AKI, no HD. Final SCr 1.1 NS
157c	7545, once	-	6.1	AKI, no HD. Final SCr 1.2
157d	1300, once	-	5.7	AKI, no HD. Final SCr 1.0
157e	2170, once	-	4.5	AKI, no HD. Final SCr 1.1
158	6830, once	-	16.4	AKI, no HD. SCr 0.9 mg/dL in 1 mo

¹During recovery. SCr approximately 1.7-1.8 mg/dL;

²Post-ingestion. SCr approximately 3.6 mg/dL;

³During AKI. SCr approximately 6.4 mg/dL;

⁴Post recovery. a,b,c,d,e,f,g,h,i,j,k in Ref. 153 and a,b,c,d,e in Ref. 157 represent the numerical sequence of the patients in these references (1^st, 2^nd, etc). SCr 1.3 mg/dL. SCr: Serum creatinine; AKI: Acute kidney injury; CKD: Chronic kidney disease; ESRD: End-stage renal disease; HD: Hemodialysis; NS: Not specified duration of intake.